Long-term, real-world effectiveness of natalizumab treatment in relapsingremitting multiple sclerosis: Data from ≥6 years in the TYSABRI® Observational Program (TOP) Portuguese, Spanish, and global cohorts

Authors
Category Primary study
JournalEuropean Journal of Neurology
Year 2018
This article has no abstract
Epistemonikos ID: 468e22060af40c8f46db8950285b1da770400a54
First added on: Feb 09, 2025